Vaxxa AB
Vaxxa AB operates an auction platform, vaxxa.se, which offers private individuals and companies to sell and buy used objects in vehicles, machinery, and construction industry. The company was formerly known as Augeo Group AB and changed its name to Vaxxa AB in July 2023. Vaxxa AB was incorporated in 2015 and is based in Stockholm, Sweden.
Vaxxa AB (7WA0) - Total Assets
Latest total assets as of June 2025: €24.13 Million EUR
Based on the latest financial reports, Vaxxa AB (7WA0) holds total assets worth €24.13 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Vaxxa AB - Total Assets Trend (2021–2024)
This chart illustrates how Vaxxa AB’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Vaxxa AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Vaxxa AB's total assets of €24.13 Million consist of 57.3% current assets and 42.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 36.8% |
| Accounts Receivable | €5.46 Million | 19.6% |
| Inventory | €49.00K | 0.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €6.67 Million | 24.0% |
| Goodwill | €5.13 Million | 18.5% |
Asset Composition Trend (2021–2024)
This chart illustrates how Vaxxa AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vaxxa AB's current assets represent 57.3% of total assets in 2024, a decrease from 62.7% in 2021.
- Cash Position: Cash and equivalents constituted 36.8% of total assets in 2024, down from 44.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, an increase from 37.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 24.0% of total assets.
Vaxxa AB Competitors by Total Assets
Key competitors of Vaxxa AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
IQuest Co. Ltd.
KQ:262840
|
Korea | ₩104.88 Billion |
|
Fujian Newland Computer Co Ltd
SHE:000997
|
China | CN¥13.83 Billion |
|
YGSOFT Inc
SHE:002063
|
China | CN¥4.58 Billion |
|
Dhc Software Co Ltd
SHE:002065
|
China | CN¥25.81 Billion |
|
Zhejiang Netsun Co Ltd
SHE:002095
|
China | CN¥1.57 Billion |
|
Montnets Cloud Technology Group Co Ltd
SHE:002123
|
China | CN¥3.29 Billion |
|
Beijing Shiji Information Technology Co Ltd
SHE:002153
|
China | CN¥9.36 Billion |
|
Shanghai 2345 Network Holding Group
SHE:002195
|
China | CN¥10.73 Billion |
Vaxxa AB - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Vaxxa AB generates 2.93x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Vaxxa AB generates $ 1.39 in net profit.
Vaxxa AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.83 | 2.70 | 2.70 |
| Quick Ratio | 6.80 | 2.70 | 2.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €10.20 Million | € 7.20 Million | € 7.20 Million |
Vaxxa AB - Advanced Valuation Insights
This section examines the relationship between Vaxxa AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.02 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 56.4% |
| Total Assets | €27.82 Million |
| Market Capitalization | $1.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values Vaxxa AB's assets below their book value (0.06 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Vaxxa AB's assets grew by 56.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Vaxxa AB (2021–2024)
The table below shows the annual total assets of Vaxxa AB from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €27.82 Million | +56.45% |
| 2023-12-31 | €17.78 Million | +0.81% |
| 2022-12-31 | €17.64 Million | +53.65% |
| 2021-12-31 | €11.48 Million | -- |